Article
Cancer omics: from regulatory networks to clinical outcomes.
Cancer letters - 1 Nov 2013
Tang Binhua, Hsu Pei-Yin, Huang Tim H-M, Jin Victor X
Abstract excerpt
Current limitation in cancer genomic studies is a lack of the integration of various omics data generated through next generation sequencing technologies, as well as a lack of the sounding and comprehensive epigenomic and genomic information about a particular cancer cell type. In this review, we will discuss main aspects of current genomics research with its application in cancer topics. We will first overview...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
